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Background: Recent evidence has suggested that Alzheimer’s disease (AD)-associated neuronal loss may occur via
the caspase-independent route of programmed cell death (PCD) in addition to caspase-dependent mechanisms.
However, the brain region specificity of caspase-independent PCD in AD-associated neurodegeneration is unknown.
We therefore used the transgenic CRND8 (TgCRND8) AD mouse model to explore whether the apoptosis inducing
factor (AIF), a key mediator of caspase-independent PCD, contributes to cell loss in selected brain regions in the
course of aging.
Results: Increased expression of truncated AIF (tAIF), which is directly responsible for cell death induction, was
observed at both 4- and 6-months of age in the cortex. Concomitant with the up-regulation of tAIF was an increase
in the nuclear translocation of this protein. Heightened tAIF expression or translocation was not observed in the
hippocampus or cerebellum, which were used as AD-vulnerable and relatively AD-spared regions, respectively. The
cortical alterations in tAIF levels were accompanied by increased Bax expression and mitochondrial translocation.
This effect was preceded by a significant reduction in ATP content and an increase in reactive oxygen species (ROS)
production, detectable at 2 months of age despite negligible amounts of amyloid-beta peptides (Aβ).
Conclusions: Taken together, these data suggest that AIF is likely to play a region-specific role in AD-related caspase-
independent PCD, which is consistent with aging-associated mitochondrial impairment and oxidative stress.
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Alzheimer’s disease (AD) is an age-related neurodegenera-
tive disorder, histologically characterized by the extracellu-
lar deposition of amyloid β peptides (Aβ) and the
intracellular accumulation of hyperphosphorylated tau.
Numerous in vitro and in vivo studies have provided
evidence for a key role of Aβ in AD [1,2]. Aβ-associated
neurodegeneration involves cerebral cell death, but the
underlying mechanisms remain largely unknown. Animal
models of AD offer a unique opportunity to study the* Correspondence: slavica.krantic@crc.jussieu.fr
2Department of Psychiatry, Douglas Mental Health University Institute
(DMHUI), McGill University, Verdun Montréal, Québec H4H 1R3, Canada
4Centre de Recherche des Cordeliers, UMRS872, Paris, France
Full list of author information is available at the end of the article
© 2014 Yu et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.mechanisms involved in AD-related neurodegeneration,
particularly the contribution of specific types of cell death
during neuronal demise. Although neuronal death cannot
be reproduced in all mouse models of AD, brain regions
of some transgenic mice (e.g. PS1xAPP and TgCRND8)
have been reported to demonstrate an age-dependent
vulnerability, with the cortex and hippocampus being
affected the earliest [3-5].
Neurodegeneration in age-associated dementia of the
AD type is thought to involve neuronal cell loss by
programmed cell death (PCD) [6,7]. Various caspases
have been recognized as important mediators of neuronal
PCD in AD [8] by classical caspase-dependent apoptosis.
Several studies have shown the presence of activatedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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including tau and amyloid precursor protein (APP) in
post-mortem human AD brains and animal models
[9-15]. However, accumulating evidence also points to the
involvement of caspase-independent mechanisms in neur-
onal PCD [16-18]. In particular, apoptosis-inducing factor
(AIF) is considered to play a central role among key effec-
tors involved in caspase-independent neuronal cell death
[19-21]. Consistently, we have recently reported the
increased nuclear translocation of AIF in the hippocam-
pus and cortex of post-mortem human tissues derived
from AD patients [22]; this being indicative of caspase-
independent PCD via AIF.
The mitochondrial flavoprotein AIF is synthesised in the
cytoplasm as a ~ 67 kDa precursor. Its maturation involves
a proteolytical cleavage of the precursor to a ubiquitously
expressed ~ 62 kDa form [20]. Mature AIF is imbedded
into the inner mitochondrial membrane where it is
involved in organizing and/or maintaining the structural
integrity of the respiratory chain complex-I [23,24].
Indeed, deficiency in AIF expression is associated with
reduced complex-I activity and decreased ATP production
[24]. Upon pathological mitochondrial permeabilization,
AIF is further processed to a ~ 57 kDa truncated form
(tAIF) [25,26], then released from mitochondria and trans-
located to the nucleus where it participates in the induc-
tion of caspase-independent PCD [27-29].
Interestingly, Harlequin (Hq) mutant mice with reduced
expression of AIF display decreased oxidative phosphoryl-
ation in specific neuronal populations [24]. The reduced
expression of AIF in Hq mice is correlated with a lowered
expression of mitochondrial complex-I, together with
signs of oxidative stress linked to increased reactive oxy-
gen species (ROS) production in dying neurons [24,30,31].
Thus, mitochondrial dysfunction, seen in the course of
rodent brain aging, is strikingly similar to that observed in
AIF-deficient neurons, suggesting a possible relationship
between age-related decreases in AIF expression, mito-
chondrial impairment and neuronal death. This hypoth-
esis is in line with the fact that mitochondrial injury in Hq
mice, due to low AIF expression, precedes the onset of
neurodegeneration [32].
Moreover, although AIF is ubiquitously expressed in the
rodent brain, we observed a brain region-specific gradient
of distribution in the normal rat brain [33]. Such contrast-
ing levels of AIF expression indicated that AIF-induced
PCD may be region specific. To explore this possibility,
we investigated AIF-related cell death in brain regions
vulnerable to AD-like pathology in the transgenic mouse
model, TgCRND8 (Tg), at 2, 4, 6–7 and 9 months of age.
These selected ages correspond to pre-plaque, plaque
burden, overt AD-like pathology and advanced AD-like
pathology stage, respectively [34]. The cortex and hippo-
campus were compared because they are the mostaffected regions in Tg mice [35], whereas the cerebellum
was chosen as a relatively spared control region. Overall,
our data suggest that among the vulnerable brain regions,
AIF is involved in AD-associated PCD in the cortex but
not in the hippocampus.Results
Accumulation of Aβ in the cortex and hippocampus of Tg
mice is accompanied by signs of oxidative stress
We examined the Aβ load as a function of age in the cor-
tex, hippocampus and cerebellum of Tg mice. Using brain
region and age as between-subject factors, a two-way
ANOVA analysis of total Aβ levels showed significant
brain region and age interaction (F [6,36] = 7.604, p <
0.001). Multiple comparisons showed significant regional
differences in total Aβ levels, with higher levels in the cor-
tex compared to hippocampus (p = 0.025) and cerebellum
(p = 0.001).
We next investigated the levels of both Aβ1–40 and Aβ1–42
as a function of age and brain region. In all three brain
regions of 2- and 4-month-old mice, the level of Aβ1–40
(Figure 1A) and Aβ1–42 (Figure 1B) was low, only
reaching the limit of detection at 2 months while
remaining relatively low at 4 months. The difference in
the level of expression of either peptide was not signifi-
cant between these two ages in any of the brain regions
(Figure. 1A, B). In contrast, Aβ1–40 (Figure 1A) and
Aβ1–42 (Figure 1B) were significantly increased in older
(7- and 9-month-old) animals. For Aβ1–40, the observed
difference in the cortex and hippocampus was significant
for 6-7-month-old animals in comparison to younger
(either 2- or 4-month-old) mice. The level of Aβ1–42 in
the hippocampus (but not in the cortex) was significantly
different between 6-7-month-old mice and 2- or 4-
month-old groups (Figure 1B). In all brain regions, includ-
ing the cerebellum, the difference was significant for the
comparison between 9-month-old animals and all other
ages for both Aβ1–40 and Aβ1–42 (Figure 1A and B).
Oxidative stress has been proposed to increase with Aβ
peptide accumulation. We therefore undertook a parallel
assessment of oxidative stress, via the quantification of
ROS. The alterations seen in the cortex indicated the es-
tablishment of oxidative stress in the course of brain aging
(Figure 2A). Interestingly in this region, ROS production
was significantly higher in Tg than in non-Tg mice as early
as 2 months of age. Moreover, the difference in ROS pro-
duction between the two genotypes was significant in all
age groups, except for the 4-month old mice (Figure 2A).
Comparison between cortical ROS levels among trans-
genic animals indicated a significant increase in the
course of aging (except for the 4-month-old group)
when 2-month-old Tg mice were taken as a reference
value (Figure 2A).
Figure 1 Expression of different Aβ species in the Tg mice. (A): The levels of total Aβ1–40 were assayed by ELISA in cortical, hippocampal and
cerebellar extracts of Tg mice at indicated ages. (B): The levels of total Aβ1–42 were determined by ELISA in cortical, hippocampal and cerebellar
extracts of Tg mice at indicated ages. *P < 0.05; #P < 0.01; ##P < 0.001; ###P < 0.0001.
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difference in ROS levels was seen between 4- and 6-
month-old groups (Figure 2A). In contrast, in 2- and 9-
month-old groups, the difference between Tg and non-Tg
mice was not significant (Figure 2A). However, comparing
the level of ROS between the ages in transgenic animals
revealed that it was significantly higher in all ages when
compared to 2-month-old Tg mice (Figure 2A). No signifi-
cant difference was observed between either genotype or
age in the cerebellum (Figure 2A), confirming this brain
region as a negative control.
To further explore the establishment of oxidative stress
in the course of aging in the three brain regions, we stud-
ied the level of expression of neuronal nitric oxide syn-
thase (nNOS). A moderate increase in expression of
nNOS was observed between 2- and 9-month-old mice in
both cortex and hippocampus but the difference was onlystatistically significant in the hippocampus (Figure 2B). In
contrast to the cortex and hippocampus but in agreement
with ROS levels, no difference was found in the cerebel-
lum (Figure 2B).
As mitochondria are known to be causally involved in
the establishment of oxidative stress and a target of Aβ
toxicity, we aimed to further investigate function by
comparing the level of ATP production between Tg and
non-Tg mice. These experiments revealed a slightly de-
creased production of ATP in vulnerable areas (cortex and
hippocampus) of most age groups of Tg mice versus age-
matched non-Tg. However, the difference was greater at
the younger stages and was only significant in the cortex
of the 2-month-old group (Figure 3). All other compari-
sons, and specifically those for the cerebellum, indicated a
similar level of ATP production between the two geno-
types and age groups (Figure 3).
Figure 2 Markers of oxidative stress in the Tg mice. (A): ROS expression in cortex, hippocampus and cerebellum of Tg mice as compared to
their non-Tg littermates of the indicated ages. White- and black bars depict the values determined for non-Tg and Tg mice, respectively. (B): nNOS
quantification in cortex, hippocampus and cerebellum of Tg mice as compared to their non-Tg littermates of the indicated ages. Equal protein loading
was confirmed by detection of β-actin. *P < 0.05; #P < 0.01; ##P < 0.001; ###P < 0.0001.
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hippocampus of aging Tg mice
To assess neuronal death, we focused on indirect markers
of cell death because it is extremely difficult to directly
quantify the number of dead neurons in AD mouse
models [37-39]. In agreement, our attempts to quantify
neuronal death by TUNEL assay didn’t reveal significant
differences between genotypes (data not shown) in spite
of the fact that loss of specific sub-types of neurons has
been reported by 6 months of age in TgCRND8 [3,40]. In
order to assess the extent of cell death in the brain of Tg
mice, we determined the levels of the universal pro-
apoptotic protein, Bax, and the induction of cyclin D1, the
latter is considered to be an early commitment step in
neuronal cell death.
The universal involvement of this BCl2 family member,
Bax, in cell death has been largely demonstrated [41].
Moreover, Bax has recently been shown to be directly in-
volved in Aβ toxicity to neurons [36]. In our experiments,the cortical expression of Bax is significantly increased in
4- and 6-7-month-old Tg animals when compared to the
2-month-old group (Figure 4A). Since it has been reported
that gender may impact the expression of BCl2 family
members and because we used sex-balanced groups of
mice in our study, we investigated whether the level of
Bax expression differed between males and females. We
found no significant difference for either genotype (nTg
p = 0.42; Tg p = 0.46). Because the death-inducing activ-
ity of Bax relies on its translocation from cytoplasm to
mitochondria [41,42], we assessed the distribution of Bax
between these two cellular compartments by performing
the sub-cellular fractionation experiments. Our data show
increased mitochondrial Bax translocation in 4- and
6 months aged TgCRND8 mice (Figure 4B), which is com-
patible with cell death induction. By contrast, there was
no significant difference between the level of active Bax
expression in cerebellum and hippocampus (Figure 4A).
However, in contrast to cerebellum, hippocampus displayed
Figure 3 ATP levels in the Tg mice and corresponding non-Tg
littermates at indicated ages. ATP is expressed in μmol ATP/mg
protein. *P < 0.05; #P < 0.01; ##P < 0.001; ###P < 0.0001.
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where only the difference between the youngest (2 months)
and oldest (9 months) groups was significant (Figure 4A).
The induction of cyclin D1 is considered to precede
neuronal death in some pathological paradigms. For ex-
ample, cyclin D1 induction is related to excitotoxicity,
which is known to be tightly associated with oxidative
stress and is correlated with increasing Aβ levels [43,44].
Moreover, cyclin D1 induction has been involved in neur-
onal death, as shown in hippocampal [45,46] and cortical
[47,48] neurons, in vitro, as well as animal and human AD
post-mortem tissues [49,50]. In the current study, no
difference was noted with age in any of the regions studied
(Figure 4C). These results indicate that the strength of the
cell death-inducing capacity of Aβ, as reflected by in-
creased Bax levels of expression and mitochondrial trans-
location, which irreversibly direct cells to PCD, may be
non-permissive for cyclin D1 induction. Consistently, cyc-
lin D1 induction is generally considered as a part of the
cell defence response to initially mild (reparable) DNA
damage related to oxidative stress [51].Cell death in the cortex, but not in the hippocampus, is
associated with AIF in aging Tg mice
The cortical expression of tAIF (57 kDa) was similar at
4- and 6-months-of-age and significantly higher than in
the youngest and the oldest groups studied (Figure 5A).
The expression of tAIF was not different between the age
groups in either hippocampus or cerebellum (Figure 5B
and 5C, respectively). Interestingly, the level of expression
of the mitochondrial form (62 kDa) was significantly higher
in the hippocampus of 6-month-old Tg mice compared with
the other ages studied (i.e. 2, 4 and 9 months) (Figure 5B).
The 62 kDa form was not altered with age in either cortex
or cerebellum relative to non-Tg littermate levels (Figure 5A
and 5C, respectively). However, independently of the geno-
type, the level of expression of the 62 kDa form appears
higher in the cerebellum (Figure 5C: western blot scan)
compared to the other two regions (Figure 5A and 5B: rele-
vant western blot scans), which is in agreement with a gen-
eral view that this brain region displays lower vulnerability
to AD compared to the cortex and hippocampus.
To confirm the biochemical data pointing to the
involvement of AIF in cell death in the cortex of 4- and 6-
month-old Tg mice, we assessed the histological signature
of AIF nuclear translocation and cell death induction [22]
using immunohistochemistry. We examined the popula-
tion of cells in which nuclear exclusion from AIF staining
is no longer visible. In agreement with the biochemical
data, a low number of cells without nuclear exclusion
from AIF staining was seen in the cortex of 2-month-old
mice (Figure 6A and 6B), with similar low numbers in 9-
month-old mice (Figure 6G and 6H) irrespective of their
genotype (non-Tg: Figure 6A and 6G and Tg: Figure 6B
and 6H). In contrast, at 4 and 6–7 months of age, more
cells with nuclear exclusion from AIF staining were appar-
ent in Tg (Figure 6D and 6F) than in non-Tg (Figure 6C
and 6E) mice. The occurrence of nuclear translocation of
AIF has been further confirmed with higher resolution by
using confocal microscopy (Figure 7). Moreover, the ana-
lysis of the co-localization profiles of AIF (red) and DAPI-
stained nuclei (blue) clearly indicate the presence of AIF
in the nuclear compartment of cells in which AIF has
translocated to the nucleus (Figure 7B).
Discussion
The main finding of this study showed that the cleavage
of AIF into cell death-inducing tAIF increased in the
course of aging and Aβ accumulation selectively in the
cortex of the Tg mouse model of AD studied. Moreover,
the age-dependent increase in tAIF was not found in
other vulnerable (hippocampus) or relatively spared (cere-
bellum) brain areas further pointing to the specificity of
the observed alterations in the cortex. These results are
the first to indicate the contribution of the key mediator
of caspase-independent programmed cell death, AIF, to
Figure 4 Cell death markers expression in cortical, hippocampal and cerebellar extracts from Tg mice and age-matched non-Tg littermates.
(A): Bax quantification in the studied brain areas as determined by Western blotting. Equal protein loading was ascertained by the parallel assessment
of β-actin. (B): Bax translocation as assessed by western blot probing of Bax in mitochondrial versus total Bax expression. The percentage of translocation
was calculated as indicated in Materials and Methods after normalization for the equal loading over GAPDH and Cox IVb O.D. for cytoplasmic and
mitochondrial fractions, respectively. (C): Cyclin D1 quantification by Western blotting in the same brain regions as in (A). Results are expressed as the
ratio of the values calculated for the transgenic over non-Tg mice. *P < 0.05; **P < 0.01; #P < 0.01; ##P < 0.001; ###P < 0.0001.
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model of AD-like pathology.
Furthermore in our study, cortical oxidative stress in Tg
mice was found to occur as early as the pre-plaque
stage (i.e. 2 months), thus greatly preceding the onset
of plaque burden (3–4 months) [34,40] and cell loss (6–7
months) [3,40]. These findings validate our methodological
approaches, as they are in agreement with previously pub-
lished data in other AD mouse models demonstrating the
relationship between oxidative stress, Aβ and Aβ plaque
accumulation [52-56]. Interestingly, the first signs of mito-
chondrial dysfunction, including signs of oxidative stress
such as increased ROS production, coincide with the intra-
cellular accumulation of Aβ and continue to accumulate
with further increases in Aβ and its deposition into plaques
in Thy-1 APP mice [54]. In addition, our results point to a
higher Aβ load in the cortex than in the hippocampus and
cerebellum of TgCRND8 mice. Moreover, despite a generaltrend towards the up-regulated production of ROS in both
hippocampus and cortex of the youngest (2-month-old)
mice, this increase was only significant in the cortex. These
results are in line with the recently published data in APP/
PS1 mice where oxidative stress is specifically increased in
the cortex before evidence of plaque burden [53].
Besides, the increase in the level of ROS was accom-
panied by decreased ATP production only in the cortex
of the youngest (i.e. 2 months) age group studied, fur-
ther suggesting early mitochondrial dysfunction in this
brain region. These results may not be surprising since
creatine levels have been reported to rise with age, and
this might function to buffer ATP production [57]. Re-
markably, the study of the mitochondrial proteome has
recently identified an early alteration in expression of
more than 20 proteins, among others involved in oxida-
tive stress and apoptosis, specifically in the cortex of an-
other mouse model of Alzheimer’s disease [52].
Figure 5 AIF expression in cortical (A), hippocampal (B) and
cerebellar (C) extracts from Tg mice and their age-matched
non-Tg littermates at indicated ages. Both mitochondrial (62 kDa,
white bars) and tAIF (57 kDa, black bars) forms of AIF were studied.
Equal protein loading was confirmed by detection of β-actin. Results
were expressed as the ratio of the values calculated for the transgenic
over non-Tg mice. *P < 0.05; #P < 0.01; ##P < 0.001; ###P < 0.0001.
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our study preceded the increased production of tAIF
and its nuclear translocation, both of which were aug-
mented in cortices of mid-aged (4- and 6-month-old) Tg
mice. Taken together, these data may suggest a causal re-
lationship between mitochondrial impairment/oxidative
stress and AIF-mediated caspase-independent PCD in this
transgenic AD mouse model. In addition, these findings
confirm and extend previous reports on the causal relation-
ship between early mitochondrial dysfunction and multiple
AD-associated cell death pathways including caspase-
dependent apoptosis and autophagic pathways [52,56,58].
Despite the observed genotypic differences in ROS
levels, the production of ATP was similar between trans-
genic and non-Tg mice during aging (excluding 2-
month-old transgenics). Previous studies have described
differences in distinct ROS scavenging capacity as well
as metabolic and intracellular signalling between the
cortex and hippocampus [52,55,59,60]. Therefore, the
differential sensitivity of mitochondrial ATP production
and increased ROS between these two regions reported
herein may be associated with their respective level of
expression of AIF. In agreement with this hypothesis,
our previous study revealed significant differences in the
level of AIF expression between brain regions of the
rodent brain [33]. Furthermore, low level of AIF expres-
sion in Harlequin mice has been linked to mitochondrial
respiratory chain dysfunction [24] and AIF has been
implicated in ROS production [61]. Therefore, it is
plausible that the tissue level of AIF may be related to
the degree of Aβ-induced oxidative stress and subse-
quent AIF-mediated cell death.
Age-related cell death in Tg mice was demonstrated in
this study by increased levels of cortical tAIF and Bax in
the mid-aged groups (4- and 6-month old). However, in
the oldest group (9-month-old Tg mice) AIF-mediated
cell death was not evident, as indicated by the absence
of increased tAIF and Bax. This apparent paradoxical
observation may be related to the limited, yet still sig-
nificant, neuronal loss observed in our model, starting
by 6–7 months of age [3,40].
Cell death in the hippocampus has been documented
at 6 months of age in TgCRND8 mice [40]. Interestingly
in this study, the hippocampal level of Bax was not in-
creased before 9 months and no significant age-dependent
increase was seen in the level of tAIF, suggesting that
Figure 6 Cellular expression of AIF in the cortex of Tg (B, D, F and H) and non-Tg littermate (A, C, E and G) mice shown at indicated ages.
Arrows point to the cells displaying the tAIF translocation to the nucleus. Bar = 30 μm.
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at least up to 9 months of age. In the hippocampus of
the two mid-aged groups, the absence of deleterious effects
(despite high levels of ROS) is suggested to be the result of
compensated production of ATP, which may be related to
the increased expression of the mitochondrial, 62 kDa, form
of AIF. An increased expression of this form of AIF may
provide more efficient respiratory chain function due to, at
least in part, more efficient complex I and III function [24].
Cyclin D1 expression, used here as an early marker of
neuronal cell death, was similarly expressed between dif-
ferent age groups in all brain regions. Although cyclin
D1 induction has been associated with Aβ-induced cell
death, in vitro and in human post-morten AD brain
tissues [45,48-50], the data are much less conclusive
regarding the relationship of cyclin D1/Aβ in AD mouse
models [50,62].Conclusion
Overall, our data suggest that in the course of aging, AIF
may play a different role in AD-related caspase-independent
PCD, depending on the brain region and relative contribu-
tion of multiple PCD pathways to neurodegeneration. Since
caspase-dependent apoptosis has been reported to
occur both in the cortex and in the hippocampus [58],
future therapeutic strategies should take into the account
a multi-therapeutic approach targeting both caspase-
dependent and caspase-independent PCD.
Methods
Reagents
Rabbit monoclonal anti-cyclin D1 was purchased from
Neomarker (RM-9104-S1, Kalamazoo, MI, USA). Rabbit
polyclonal anti-nNOS (sc-49055), anti-AIF (sc-9416),
HRP (horseradish peroxidase)-conjugated goat-anti-
Figure 7 Confocal microscopy analysis of subcellular distribution of AIF in the cortex of Tg and non-Tg littermate mice shown at indicated
ages. (A) Arrows point to the cells displaying the tAIF translocation to the nucleus which contrasts with the punctuate labelling in the cytoplasm
reminiscent of mitochondrial localization. (B) The nuclear tranlocation of AIF was further analyzed by co-localization analysis of red and blue
fluorescence corresponding to AIF and DAPI (used to stain the nuclei), respectively. Bar =10 μm.
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IgG (sc-47778 HRP) were obtained from Santa Cruz
(Dallas, Texas, USA). Mouse monoclonal anti-Bax (556
467) was from BD Pharmingen (Qume Drive San Jose, CA,
USA) whereas mouse monoclonal anti-cytochrome C
(13575) and mouse monoclonal anti-COX IVb (110226)
were from Abcam (Cambridge, MA, USA). Goat anti-
rabbit IgGs conjugated with Alexa Fluor 568 used as a sec-
ondary antibody for immunocytochemistry was purchased
from Jackson ImmunoResearch Laboratories (111-165-144,West Grove, PA, USA). Rabbit polyclonal anti-GAPDH
(G9545) and all other chemicals were from Sigma-Aldrich
(Oakville, Ontario, Canada).
Animal breeding and Aβ assays in brain tissue extracts
The TgCRND8 mouse has been relatively well character-
ized and presents an advantage in developing AD-like
pathology relatively fast. By the age of 3–4 months, these
mice over-express human Aβ, encoded by a double mu-
tated form of hAPP (695 (Swedish KM670/671NL and
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cits and Aβ pathology progress in the course of aging and
from 6–7 months of age, these mice have a high Aβ42/
Aβ40 ratio and severe plaque load in many brain regions,
including the hippocampus and cortex [34,63].
All experiments using mice followed the policies and
guidelines of the Canadian Council on Animal Care, the
Animal Care regulations of the University of Toronto
and of McGill University on the use of laboratory
animals and the U.S. National Institutes of Health Guide
for the Care and Use of Laboratory Animals. Efforts
were always made to minimize the numbers of animals
used and their distress. Sex-balanced groups of TgCR
ND8 mice were maintained on an outbred C3H/C57BL6
background and kept on a 12 h light/dark cycle with
food and water ad libitum. Four to 6 animals per experi-
mental group were analyzed.
Brains from 2-, 4-, 6-7- and 9-month-old Tg and non-
transgenic littermates (non-Tg) were dissected on ice in
order to retrieve the hippocampus, cortex (to assess the
vulnerable areas) and cerebellum (chosen since it is rela-
tively spared in AD). Only Tg mice were analysed for
total Aβ using a formic acid extraction procedure. Aβ1–
42 and Aβ1–40 content in dissected samples were quanti-
fied with commercially available sandwich ELISA kits
(Invitrogen, Burlington, ON, Canada) as described previ-
ously [63].
ATP content
ATP content was determined in homogenates obtained
from the studied brain regions by the high sensitivity
ATP determination kit (Interchim, Montlucon Cedex,
France) as per the manufacturer’s instructions. Briefly,
brain regions were homogenized in 1 mM Tris-acetate
buffer containing 2 mM EDTA and 15 μg of protein in
brain homogenates was analysed. ATP disodium salt was
used to prepare standard curves ranging from 10 nM to
1 mM. Luminescence was quantified by Synergy 4 (Biotek,
Winooski, VT, USA) at the emission wavelength of 560 nm.
Reactive Oxygen Species (ROS) quantification
ROS was quantified by using the conversion of non-
fluorescent Dichlorodihydrofluorescein Diacetate (H2D
CFDA) into the fluorescent 2′,7′-dichlorofluorescein
(DCF) after cleavage by intracellular esterases and subse-
quent oxidation. In order to set up conditions for our
assay, we optimized the protein concentration (50, 25 or
10 μg), incubation time (30 min, 3 h, 6 h30, 22 h and
24 h at 37°C) and presence of 50 μM H202. These pre-
liminary experiments (data not shown) allowed us to de-
termine the following experimental conditions: 20 μg of
proteins per assay, 40 min incubation at 37°C and then
addition of 50 μM H2O2, followed by 5 min incubation
at room temperature. The brain region homogenatesused for ROS quantification were prepared in RIPA
buffer as previously reported [33]. The fluorescence was
quantified at the excitation/emission wavelength of 485/
530 nm (Synergy 4, Biotek, Winooski, VT, USA). ROS
production was expressed as a ratio of the production
determined for TgCRND8 over that found for non-Tg
mice within an interval of less than three days of age in
order to decrease the inter-mouse variability.
Subcellular fractionation and Bax translocation assay
Brain tissue was lysed in RIPA buffer (20 mM Tris–HCl,
pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% IgepalCA-630,
0.1% sodium dodecylsulfate (SDS), 50 mM NaF, 1 mM
NaVO3; 2 mM phenylmethylsulfonyl fluoride, 10 μg/ml
leupeptin, 50 μg/ml aprotinin) on ice for 30 min. Cell
lysates were centrifuged at 15,000 × g for 15 min at 4°C
twice, and the resulting supernatant, representing the
cytosolic fraction, was recovered. The mitochondrial
fraction was isolated with the Mitochondria Isolation
Kit. Briefly, the harvested cell pellet was suspended in
isolation reagent A and incubated on ice for 2 min, next
the cell suspension was lysated in Dounce Tissue
Grinder on ice, an equal volume of isolation reagent C
was added into the cell lysate and was mixed by inverting
the tube several times. After centrifugation at 700 × g for
10 min at 4°C, the supernatant was further centrifuged at
12,000 × g for 15 min at 4°C. The pellet containing the iso-
lated mitochondria was re-suspended in RIPA buffer.
After western blot assessment (see below), the percent-
age of mitochondrial Bax translocation was calculated as a
fraction of Bax probed in mitochondrial fraction out of
total Bax (Bax probed in the mitochondrial fraction + Bax
probed in the cytoplasmic fraction). The relative quantities
of Bax were determined as a ratio of R.O.D measured for
Bax in each cellular fraction after normalization over
COX IVb and GAPDH for mitochondrial and cytoplasmic
fractions, respectively. To allow the comparison between
ages, the percentage of Bax translocated to mitochondria
in TgCRND8 mice was normalized over the perceentage
of Bax translocated to mitochondria in non-transgenic an-
imals taken as a reference (100%).
Western blot quantification
Protein extracts were prepared by using RIPA buffer
extraction as previously reported [33]. Briefly, 40 μg of
total proteins, diluted in Laemli buffer (Sigma-Aldrich,
Oakville, Ontario, Canada), were boiled for 5 min and
then separated by SDS-PAGE, on a Tris-Glycine 4-20%
gradient gel (Invitrogen, Burlington, ON, Canada), at
130 V for 2 ½ h. Proteins were transferred to nitrocellu-
lose membranes at 80 V for 45 min at 4°C, under agita-
tion. Membranes were incubated with 5% skim milk
diluted in Tris-buffered saline (TBS) containing 0.05%
Tween (TBS-T) for 1 h at room temperature and then
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skim milk diluted in TBS-T. Three washes of 5 min in
TBS-T were performed and then secondary antibodies
were incubated for 1 h at room temperature in 1% milk
TBS-T. After washings, the following primary antibodies
were used: anti-nNOS (1:1000), anti-AIF (1: 5000), anti-
cyclin D1 and anti-Bax (both in 1:500 dilution). The
HRP-conjugated goat-anti-rabbit IgG was applied as a sec-
ondary antibody in parallel with the HRP-conjugated anti-
β-actin IgG (both in 1:5000 dilution), used as an internal
standard for equal loading. Visualization was performed
using Western lightning chemiluminescence Reagent Plus
kit (Perkin-Elmer, Waltham, MA, USA). Densitometric
analysis of the immunoreactive bands was performed
using Scion Image software (Scion Corporation, Frederick,
MA, USA). The optical density (OD) measured for each
immune-reactive band was normalized to β-actin. In
agreement with our previous study of normal rat brain
aging [33], AIF expression was relatively stable for each
studied brain region in the course of non-Tg aging. Rele-
vant AIF expression in non-Tg mice was therefore taken
as a reference and results were expressed as the ratio of
the values calculated for transgenic over the non-Tg mice
analyzed on the same films and expressed as relative
optical density (R.O.D).Immunohistochemistry of AIF-immunoreactive neurons in
Tg mice and their non-Tg littermates
Transgenic and non-Tg littermates (age-matched at 2, 4,
6–7 and 9 months) were transcardially perfused with
cold PBS-heparin and their brains isolated, post-fixed in
formaldehyde and embedded in paraffin [47], and after
slicing into 8 μm-thick coronal sections, immunohisto-
chemistry proceeded. Briefly, sections were first incubated
with 10% normal goat serum (NGS) in 0.05 M TBS for 1 hr
at RT. For antigen retrieval, sections were incubated in
0.05 M citrate-buffered saline (pH 6.0) for 10 min at 95°C.
Primary incubation followed overnight at 4°C with anti-AIF
antibody in TBS (1:300 dilution). Subsequently, sections
were incubated for 1 hr at RT with goat anti-rabbit IgGs
conjugated with Alexa Fluor 568 (1:200) and then incubated
with DAPI (2 μg/ml) for 30 min at RT. Sections were
washed in TBS (3 × 5 min) between incubations. AIF immu-
noreactivity (AIF-ir) was labelled in red and nuclei in blue.Statistical analysis
GraphPad Prism 5 (GraphPad Software, San Diego, CA)
or IBM SPSS Statistics 20 was used for statistical analyses.
Independent t-tests were used to compare the mean group
values. The mean values of three or more groups were
compared with one- or two-way ANOVA and Neuman-
Keuls’ post-test. In all cases, significance was noted at
p < 0.05 (*), p < 0.01 (**), p < 0.001 (***). Figures wereprepared with Adobe Photoshop CS4 Extended, version
11.0 (Adobe Systems Inc., San Jose, CA).
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